Modular biomarker validation services – IBBL
The LIH-IBBL Translational Biomarker Group offers SMEs pre-analytical and analytical validation as well as clinical verification of novel biomarkers. Services are targeted at SMEs from Northwest Europe and other European regions developing biomarkers for diagnostics.
The costs for the service of up to 30000€ are covered by the Interreg NWE Codex4SMEs project. Deadline: 31 January 2023 | 12:00 CET
Stay informed about the latest trends and developments in digital health by subscribing to our newsletter
